Losartan may inhibit the progression of liver fibrosis in chronic HCV patients
- Citation:
- Salama, Z. A., A. Sadek, A. M. Abdelhady, S. K. Darweesh, S. A. Morsy, H. Ghoneim, and G. Esmat,
"Losartan may inhibit the progression of liver fibrosis in chronic HCV patients",
HepatoBiliary Surg and Nutrition, vol. 5, issue 3, pp. 249-255, 2016.